{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:33:34Z","timestamp":1791232414886,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T00:00:00Z","timestamp":1491177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To assess short\u2010 to medium\u2010term cancer control rates and side effects of focal salvage high\u2010 intensity focused ultrasound (\n                      <jats:styled-content style=\"fixed-case\">HIFU<\/jats:styled-content>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective registry analysis identified 150 men who underwent focal salvage HIFU (FS\u2010HIFU) (Sonablate 500) between November 2006 and August 2015. Metastatic disease was excluded by nodal assessment on the pelvic\n                      <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content>\n                      , a radioisotope bone scan and positron\u2010emission tomography (\n                      <jats:styled-content style=\"fixed-case\">PET<\/jats:styled-content>\n                      ) imaging (choline\u201018F\u2010fluorodeoxyglucose\n                      <jats:styled-content style=\"fixed-case\">PET<\/jats:styled-content>\n                      or choline\n                      <jats:styled-content style=\"fixed-case\">PET<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content>\n                      ). In our current clinical practice, metastatic disease must be excluded by both choline\n                      <jats:styled-content style=\"fixed-case\">PET<\/jats:styled-content>\n                      and bone scan. Localization of cancer was carried out using multiparametric\n                      <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content>\n                      of the prostate (T2\u2010weighted, diffusion\u2010weighted and dynamic contrast\u2010enhanced imaging) with systematic or template prostate mapping biopsies. The primary outcome was a composite failure incorporating biochemical failure (\n                      <jats:styled-content style=\"fixed-case\">BCF<\/jats:styled-content>\n                      ) and\/or positive localized or distant imaging results and\/or positive biopsy and\/or systemic therapy and\/or metastases\/prostate cancer\u2010specific death. The secondary outcome was\n                      <jats:styled-content style=\"fixed-case\">BCF<\/jats:styled-content>\n                      using the Phoenix\u2010\n                      <jats:styled-content style=\"fixed-case\">ASTRO<\/jats:styled-content>\n                      definition (prostate\u2010specific antigen [\n                      <jats:styled-content style=\"fixed-case\">PSA<\/jats:styled-content>\n                      ] nadir + 2\u00a0ng\/mL). We used Kaplan\u2013Meier analysis and Cox proportional hazards regression to quantify the effect of the determinants on the endpoints.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean (standard deviation [\n                      <jats:sc>sd<\/jats:sc>\n                      ]) patient age at focal salvage\n                      <jats:styled-content style=\"fixed-case\">HIFU<\/jats:styled-content>\n                      was 69.8 (6.1) years and the median (interquartile range [\n                      <jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content>\n                      ])\n                      <jats:styled-content style=\"fixed-case\">PSA<\/jats:styled-content>\n                      pre\u2010focal salvage\n                      <jats:styled-content style=\"fixed-case\">HIFU<\/jats:styled-content>\n                      was 5.5 (3.6\u20137.9) ng\/\n                      <jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>\n                      . The median (\n                      <jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content>\n                      ) follow\u2010up was 35 (22\u201352) months. Patients were classified as having low\u2010 2.7% (4\/150), intermediate\u2010 39.3% (59\/150) and high\u2010risk disease 41.3% (62\/150) according to D'Amico classification, prior to focal salvage\n                      <jats:styled-content style=\"fixed-case\">HIFU<\/jats:styled-content>\n                      . Composite failure occurred in 61% of patients (91\/150) and\n                      <jats:styled-content style=\"fixed-case\">BCF<\/jats:styled-content>\n                      occurred in 51.3% (77\/150). The Kaplan\u2013Meier composite endpoint\u2010free survival (\n                      <jats:styled-content style=\"fixed-case\">CEFS<\/jats:styled-content>\n                      ) rate at 3\u00a0years was 40% (95% confidence interval [\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      ] 31\u201350) for the entire group. Kaplan\u2013Meier estimates of\n                      <jats:styled-content style=\"fixed-case\">CEFS<\/jats:styled-content>\n                      were 100%, 49% and 24% at 3\u00a0years in the low\u2010, intermediate\u2010 and high\u2010risk groups pre\u2010salvage\n                      <jats:styled-content style=\"fixed-case\">HIFU<\/jats:styled-content>\n                      , respectively. The Kaplan\u2013Meier biochemical disease\u2010free survival (\n                      <jats:styled-content style=\"fixed-case\">BDFS<\/jats:styled-content>\n                      ) rate at 3\u00a0years was 48% (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      39\u201359) for the entire group. Kaplan\u2013Meier estimates of\n                      <jats:styled-content style=\"fixed-case\">BDFS<\/jats:styled-content>\n                      were 100%, 61% and 32% at 3\u00a0years in the low\u2010, intermediate\u2010 and high\u2010risk groups pre\u2010salvage\n                      <jats:styled-content style=\"fixed-case\">HIFU<\/jats:styled-content>\n                      , respectively. Complications included urinary tract infection (11.3%; 17\/150), bladder neck stricture (8%; 12\/150), recto\u2010urethral fistula after one\n                      <jats:styled-content style=\"fixed-case\">HIFU<\/jats:styled-content>\n                      procedure (2%; 3\/150) and osteitis pubis (0.7%; 1\/150).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Focal salvage\n                      <jats:styled-content style=\"fixed-case\">HIFU<\/jats:styled-content>\n                      conferred a relatively low complication and side effect rate.\n                      <jats:styled-content style=\"fixed-case\">CEFS<\/jats:styled-content>\n                      and biochemical control in the short to medium term were reasonable, especially in this relatively high\u2010risk cohort, but still low compared with current whole\u2010gland salvage therapies. Focal salvage therapy may offer disease control in men at high risk whilst minimizing additional treatment morbidities.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.13831","type":"journal-article","created":{"date-parts":[[2017,3,4]],"date-time":"2017-03-04T06:15:22Z","timestamp":1488608122000},"page":"246-256","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Focal salvage high\u2010intensity focused ultrasound in radiorecurrent prostate cancer"],"prefix":"10.1111","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1599-2455","authenticated-orcid":false,"given":"Abi","family":"Kanthabalan","sequence":"first","affiliation":[{"name":"Division of Surgery and Interventional Science University College London London UK"},{"name":"Department of Urology University College London Hospitals NHS Foundation Trust London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7981-5768","authenticated-orcid":false,"given":"Max","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology University Medical Centre Utrecht Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Van Vulpen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology University Medical Centre Utrecht Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"McCartan","sequence":"additional","affiliation":[{"name":"Division of Surgery and Interventional Science University College London London UK"},{"name":"Department of Urology University College London Hospitals NHS Foundation Trust London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Graham","family":"Hindley","sequence":"additional","affiliation":[{"name":"Department of Urology Hampshire Hospitals NHS Foundation Trust Basingstoke UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Emara","sequence":"additional","affiliation":[{"name":"Department of Urology Hampshire Hospitals NHS Foundation Trust Basingstoke UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Moore","sequence":"additional","affiliation":[{"name":"Division of Surgery and Interventional Science University College London London UK"},{"name":"Department of Urology University College London Hospitals NHS Foundation Trust London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manit","family":"Arya","sequence":"additional","affiliation":[{"name":"Department of Urology University College London Hospitals NHS Foundation Trust London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Emberton","sequence":"additional","affiliation":[{"name":"Division of Surgery and Interventional Science University College London London UK"},{"name":"Department of Urology University College London Hospitals NHS Foundation Trust London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashim Uddin","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Division of Surgery and Interventional Science University College London London UK"},{"name":"Department of Urology University College London Hospitals NHS Foundation Trust London UK"},{"name":"Division of Surgery Department of Surgery and Cancer Faculty of Medicine Imperial College London London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,4,3]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.05.023"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.01.022"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.09.028"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2013.12.014"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.07.010"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1811-9"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09291.x"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.12.009"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27394"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199807000-00007"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00238-0"},{"key":"e_1_2_5_13_1","unstructured":"R: The R Project for Statistical Computing[Internet]. R: The R Project for Statistical Computing. Available at:https:\/\/www.r-project.org\/. Accessed January 2017"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13306"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09436.x"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.10933.x"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.03.147"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-013-1100-9"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.03.031"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.2014.965687"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.04.091"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26631"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2004.01.002"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.06.029"},{"key":"e_1_2_5_25_1","first-page":"38","article-title":"The value of dynamic contrast\u2010enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings","volume":"17","author":"Kara T","year":"2011","journal-title":"Diagn Interv Radiol"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.9106"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7162"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2016.07.015"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2015.07.004"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2014.44"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2393"},{"key":"e_1_2_5_32_1","unstructured":"Regression Modelling Strategies [Internet]. CRAN \u2010 Package rms. Available at:https:\/\/cran.r-project.org\/web\/packages\/rms\/index.html. Accessed January 2017"},{"key":"e_1_2_5_33_1","unstructured":"CRAN \u2010 Package survival [Internet]. CRAN \u2010 Package survival. Available at:https:\/\/cran.r-project.org\/web\/packages\/survival\/Accessed January 2017"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.13831","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.13831","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:20:59Z","timestamp":1761744059000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.13831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1111\/bju.13831"],"URL":"https:\/\/doi.org\/10.1111\/bju.13831","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,3]]},"assertion":[{"value":"2017-04-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}